Problems With Drug Absorption Studies Still ‘Relatively Common’ In EU
Inadequacies Have Drawn Major Objections During Initial EMA Review
A retrospective analysis of new drugs evaluated by the European Medicines Agency since 2010 shows that a lack of, or major deficiencies in, human mass balance studies is still a concern in regulatory submissions.
